Blog

Diagnostic tests for dengue and other arboviruses being evaluated by scientists.

ANVISA

Anvisa Prioritizes Registration of Tests for Arboviruses, Including Dengue and Chikungunya

Ler mais...

18 de October de 2024 No Comments

ANVISA

QR Group Explains Data Sharing Agreement Between Anvisa and FDA

Ler mais...

17 de October de 2024 No Comments

ANVISA

Simplifying the process: regularizing products at ANVISA

Ler mais...

16 de October de 2024 No Comments

QR Group explains how the Mais Médicos Program increases vacancies for professionals with CRM Brazil.

ANVISA

QR Group Explains the Impact of the Mais Médicos Program in Brazil

Ler mais...

15 de October de 2024 No Comments

QR Group conducts training with Health Surveillance in Nova Lima, MG and explains that there are challenges in interpreting the requirements.

ANVISA

Challenges for companies and inspectors in interpreting the requirements of legislation and international standards of Health Surveillance

Ler mais...

14 de October de 2024 No Comments

ANVISA

Registering Medical Products in Brazil – What do you need to know?

Ler mais...

4 de October de 2024 No Comments

ANVISA

Anvisa Launches Consultation Panel for Active Ingredients of Medications with Drug Registration Process

Ler mais...

3 de October de 2024 No Comments

Spending on Medication Represents 33.7% of Brazilian Families' Health Expenditure in 2021, According to IBGE

ANVISA

Spending on Medication Represents 33.7% of Brazilian Families Health Expenditure in 2021, According to IBGE

Ler mais...

1 de October de 2024 No Comments

Anvisa Publishes English Version of IN 289/2024: Regulatory Convergence and Efficiency

Importer

Anvisa Publishes English Version of IN 289/2024: Regulatory Convergence and Efficiency

Ler mais...

30 de September de 2024 No Comments

Anvisa-extends-deadline-for-innovative-medical-devices-pilot-project,-facilitating-regulation-in-Brazil

Importer

QR Group Reports: Anvisa Extends Participation Deadline in Pilot Project for Innovative Medical Devices

Ler mais...

26 de September de 2024 No Comments

In Vitro Diagnostic Devices: Update on ANVISA's Petitioning System under RDC 830/2023

Importer

In Vitro Diagnostic Devices: Update on ANVISA’s Petitioning System under RDC 830/2023

Ler mais...

9 de September de 2024 No Comments

Importação de componentes de dispositivos médicos conforme normas da Anvisa.

Anvisa Esclarece Regras de Importação para Componentes de Dispositivos Médicos: O que Fabricantes Precisam Saber

19 de December de 2024 No Comments

Ler mais...

Atualização da RDC 896/2024 sobre registro de produtos fumígenos.

Atualizações na RDC 896/2024: QR Group Explica o Processo de Registro de Produtos Fumígenos

19 de December de 2024 No Comments

Ler mais...

Gráfico sobre o aumento das importações médico-hospitalares no Brasil em 2023.

QR Group Analisa Crescimento das Importações Médico-Hospitalares

21 de November de 2024 No Comments

Ler mais...

Serviços

Linha Diagnóstica

Teste Rápido

Linha Imunofluorescência

Material Médico e Hospitalar

Catéteres

Fale Conosco

Blog

Blog

Anvisa Prioritizes Registration of Tests for Arboviruses, Including Dengue and Chikungunya

Simplifying the process: regularizing products at ANVISA

QR Group Explains the Impact of the Mais Médicos Program in Brazil

Challenges for companies and inspectors in interpreting the requirements of legislation and international standards of Health Surveillance

Registering Medical Products in Brazil – What do you need to know?

Anvisa Launches Consultation Panel for Active Ingredients of Medications with Drug Registration Process

Spending on Medication Represents 33.7% of Brazilian Families Health Expenditure in 2021, According to IBGE

Anvisa Publishes English Version of IN 289/2024: Regulatory Convergence and Efficiency

QR Group Reports: Anvisa Extends Participation Deadline in Pilot Project for Innovative Medical Devices

In Vitro Diagnostic Devices: Update on ANVISA’s Petitioning System under RDC 830/2023

Anvisa Esclarece Regras de Importação para Componentes de Dispositivos Médicos: O que Fabricantes Precisam Saber

Atualizações na RDC 896/2024: QR Group Explica o Processo de Registro de Produtos Fumígenos

QR Group Analisa Crescimento das Importações Médico-Hospitalares